Fig. 3

Sub-group analysis of the number of ni-GDMT drugs and 3-year mortality. Association between the ni-GDMT drug count and 3-year mortality rate examined using sub-group analyses; the variables were age ≥75 or <75 years, sex, presence or absence of IHD, presence or absence of diabetes, and left ventricular ejection fraction ≥40% or <40%. ni-GDMT, not included in the guideline-directed medical therapy; IHD, Ischemic Heart Disease; LVEF, left ventricular ejection fraction; DM, diabetes mellitus; CI, confidence interval; HR, hazard ratio